{"id":"https://openalex.org/W2986313496","doi":"https://doi.org/10.1248/yakushi.19-00120","title":"Risk of Euglycemic Diabetic Ketoacidosis Due to Low-carbohydrate Diet While Taking Empagliflozin: a Case Report","display_name":"Risk of Euglycemic Diabetic Ketoacidosis Due to Low-carbohydrate Diet While Taking Empagliflozin: a Case Report","alternate_titles":[],"publication_year":2019,"publication_date":"2019-10-31","ids":{"openalex":"https://openalex.org/W2986313496","doi":"https://doi.org/10.1248/yakushi.19-00120","mag":"2986313496","pmid":"https://pubmed.ncbi.nlm.nih.gov/31685745"},"language":"ja","primary_location":{"id":"doi:10.1248/yakushi.19-00120","doi":"https://doi.org/10.1248/yakushi.19-00120","is_oa":true,"landing_page_url":"https://doi.org/10.1248/yakushi.19-00120","pdf_url":"https://www.jstage.jst.go.jp/article/yakushi/139/11/139_19-00120/_pdf","source":{"id":"https://openalex.org/S2764386467","display_name":"YAKUGAKU ZASSHI","issn_l":"0031-6903","issn":["0031-6903","1347-5231"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"YAKUGAKU ZASSHI","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2986313496"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.jstage.jst.go.jp/article/yakushi/139/11/139_19-00120/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101725189","display_name":"Mariko Yamamoto","orcid":"https://orcid.org/0000-0002-3692-7313","observed_orcids":["https://orcid.org/0000-0002-3692-7313"]},"institutions":[{"id":"https://openalex.org/I4405255777","display_name":"Chutoen General Medical Center","ror":"https://ror.org/03dq5hx50","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405255777"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mariko Yamamoto","raw_affiliation_strings":["Department of Pharmacy, Chutoen General Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Chutoen General Medical Center","institution_ids":["https://openalex.org/I4405255777"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078031596","display_name":"Naohito Ide","orcid":"https://orcid.org/0000-0002-0292-3672","observed_orcids":["https://orcid.org/0000-0002-0292-3672"]},"institutions":[{"id":"https://openalex.org/I4405255777","display_name":"Chutoen General Medical Center","ror":"https://ror.org/03dq5hx50","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405255777"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naohito Ide","raw_affiliation_strings":["Department of Pharmacy, Chutoen General Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Chutoen General Medical Center","institution_ids":["https://openalex.org/I4405255777"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031815179","display_name":"Shinzo Kitajima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405255777","display_name":"Chutoen General Medical Center","ror":"https://ror.org/03dq5hx50","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405255777"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shinzo Kitajima","raw_affiliation_strings":["Department of Pharmacy, Chutoen General Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Chutoen General Medical Center","institution_ids":["https://openalex.org/I4405255777"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Masakazu Obayashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405255777","display_name":"Chutoen General Medical Center","ror":"https://ror.org/03dq5hx50","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405255777"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masakazu Obayashi","raw_affiliation_strings":["Department of Emergency and Critical Care Medicine, Chutoen General Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Emergency and Critical Care Medicine, Chutoen General Medical Center","institution_ids":["https://openalex.org/I4405255777"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kei Asada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405255777","display_name":"Chutoen General Medical Center","ror":"https://ror.org/03dq5hx50","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405255777"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kei Asada","raw_affiliation_strings":["Department of Emergency and Critical Care Medicine, Chutoen General Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Emergency and Critical Care Medicine, Chutoen General Medical Center","institution_ids":["https://openalex.org/I4405255777"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Satoru Matsushima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405255777","display_name":"Chutoen General Medical Center","ror":"https://ror.org/03dq5hx50","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405255777"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Satoru Matsushima","raw_affiliation_strings":["Department of Emergency and Critical Care Medicine, Chutoen General Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Emergency and Critical Care Medicine, Chutoen General Medical Center","institution_ids":["https://openalex.org/I4405255777"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112642642","display_name":"Masaharu Ito","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405255777","display_name":"Chutoen General Medical Center","ror":"https://ror.org/03dq5hx50","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405255777"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masaharu Ito","raw_affiliation_strings":["Department of Pharmacy, Chutoen General Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Chutoen General Medical Center","institution_ids":["https://openalex.org/I4405255777"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405255777"],"apc_list":null,"apc_paid":null,"fwci":0.7337,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.7486631,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"139","issue":"11","first_page":"1479","last_page":"1483"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7904999852180481,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7904999852180481,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.14030000567436218,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12267","display_name":"Diet and metabolism studies","score":0.05530000105500221,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/euglycemic-diabetic-ketoacidosis","display_name":"euglycemic diabetic ketoacidosis","score":0.9950000047683716},{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":0.9789999723434448},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9620000123977661},{"id":"https://openalex.org/keywords/low-carbohydrate-diet","display_name":"low-carbohydrate diet","score":0.9940000176429749},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9800000190734863},{"id":"https://openalex.org/keywords/drug-induced-ketoacidosis","display_name":"drug-induced ketoacidosis","score":0.609000027179718},{"id":"https://openalex.org/keywords/metabolic-acidosis","display_name":"metabolic acidosis","score":0.8410000205039978},{"id":"https://openalex.org/keywords/insulin-therapy","display_name":"insulin therapy","score":0.5429999828338623},{"id":"https://openalex.org/keywords/patient-education","display_name":"patient education","score":0.5059999823570251}],"concepts":[{"id":"https://openalex.org/C2775887513","wikidata":"https://www.wikidata.org/wiki/Q5373824","display_name":"Empagliflozin","level":4,"score":0.9596319198608398},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7686353921890259},{"id":"https://openalex.org/C2781283889","wikidata":"https://www.wikidata.org/wiki/Q1130148","display_name":"Diabetic ketoacidosis","level":3,"score":0.6972776651382446},{"id":"https://openalex.org/C2775849729","wikidata":"https://www.wikidata.org/wiki/Q1130148","display_name":"Ketoacidosis","level":4,"score":0.6424372792243958},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5579518675804138},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5043243169784546},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.49802494049072266},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.49688056111335754},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.4844541549682617},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.45501744747161865},{"id":"https://openalex.org/C2777451236","wikidata":"https://www.wikidata.org/wiki/Q5030940","display_name":"Canagliflozin","level":4,"score":0.4447755515575409},{"id":"https://openalex.org/C77411442","wikidata":"https://www.wikidata.org/wiki/Q181100","display_name":"Urinary system","level":2,"score":0.44233208894729614},{"id":"https://openalex.org/C2781214132","wikidata":"https://www.wikidata.org/wiki/Q1136213","display_name":"Glycosuria","level":3,"score":0.42093753814697266},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33365076780319214},{"id":"https://openalex.org/C2781232474","wikidata":"https://www.wikidata.org/wiki/Q124407","display_name":"Type 1 diabetes","level":3,"score":0.1852358877658844}],"mesh":[{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001559","descriptor_name":"Benzhydryl Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D005947","descriptor_name":"Glucose","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005960","descriptor_name":"Glucosides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007552","descriptor_name":"Isotonic Solutions","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012306","descriptor_name":"Risk","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016883","descriptor_name":"Diabetic Ketoacidosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016883","descriptor_name":"Diabetic Ketoacidosis","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050528","descriptor_name":"Diet, Carbohydrate-Restricted","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1248/yakushi.19-00120","doi":"https://doi.org/10.1248/yakushi.19-00120","is_oa":true,"landing_page_url":"https://doi.org/10.1248/yakushi.19-00120","pdf_url":"https://www.jstage.jst.go.jp/article/yakushi/139/11/139_19-00120/_pdf","source":{"id":"https://openalex.org/S2764386467","display_name":"YAKUGAKU ZASSHI","issn_l":"0031-6903","issn":["0031-6903","1347-5231"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"YAKUGAKU ZASSHI","raw_type":"journal-article"},{"id":"pmid:31685745","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31685745","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan","raw_type":"Case Reports"}],"best_oa_location":{"id":"doi:10.1248/yakushi.19-00120","doi":"https://doi.org/10.1248/yakushi.19-00120","is_oa":true,"landing_page_url":"https://doi.org/10.1248/yakushi.19-00120","pdf_url":"https://www.jstage.jst.go.jp/article/yakushi/139/11/139_19-00120/_pdf","source":{"id":"https://openalex.org/S2764386467","display_name":"YAKUGAKU ZASSHI","issn_l":"0031-6903","issn":["0031-6903","1347-5231"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"YAKUGAKU ZASSHI","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2986313496.pdf","grobid_xml":"https://content.openalex.org/works/W2986313496.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W1890354996","https://openalex.org/W1990446303","https://openalex.org/W2001227300","https://openalex.org/W2040580117","https://openalex.org/W2075224373","https://openalex.org/W2106596603","https://openalex.org/W2135161160","https://openalex.org/W2146264128","https://openalex.org/W2162693177","https://openalex.org/W2341757727","https://openalex.org/W2493466685","https://openalex.org/W2562743482","https://openalex.org/W2593546451","https://openalex.org/W2794676804","https://openalex.org/W2938193788"],"related_works":["https://openalex.org/W3040346450","https://openalex.org/W4408629321","https://openalex.org/W3121570312","https://openalex.org/W3114041437","https://openalex.org/W3048405893","https://openalex.org/W2482323928","https://openalex.org/W2944350363","https://openalex.org/W4308783329","https://openalex.org/W3023907531","https://openalex.org/W2373361583"],"abstract_inverted_index":{"Empagliflozin":[0],"reduces":[1],"blood":[2],"glucose":[3,11,170],"levels":[4],"independently":[5],"of":[6,20,32,45,63,138,146,164,173,191,212],"insulin":[7],"secretion":[8],"by":[9],"reducing":[10],"reabsorption":[12],"in":[13,78,131],"the":[14,43,127,188,209],"proximal":[15],"renal":[16],"tubules":[17],"through":[18],"inhibition":[19],"sodium-glucose":[21],"cotransporter":[22],"2":[23,82],"(SGLT2).":[24],"Because":[25],"SGLT2":[26,64,85,192,221],"inhibitors":[27,86,193],"have":[28,39,59,72],"a":[29,89,95,102,136,140,216],"different":[30],"mechanism":[31],"action":[33],"to":[34,183],"conventional":[35],"antidiabetic":[36],"drugs,":[37],"recommendations":[38],"been":[40,60,73],"issued":[41],"about":[42,76,129,187,208],"management":[44],"specific":[46],"side":[47,189],"effect":[48],"such":[49,194],"as":[50,195],"ketoacidosis,":[51,196],"urinary":[52,197],"tract":[53,198],"infection,":[54,199],"and":[55,116,118,135,153,171,181,200],"genital":[56,201],"infection.":[57,202],"There":[58],"some":[61],"reports":[62,75],"inhibitor-associated":[65],"euglycemic":[66],"diabetic":[67],"ketoacidosis":[68],"(euDKA),":[69],"but":[70],"there":[71],"few":[74],"euDKA":[77,99,123,213],"patients":[79,186],"with":[80,114,168,215],"type":[81],"diabetes":[83],"using":[84],"while":[87,106,219],"on":[88],"low-carbohydrate":[90,104,141,217],"diet.":[91],"Here":[92],"we":[93],"report":[94],"patient":[96,160],"who":[97],"developed":[98],"after":[100,162],"starting":[101],"very":[103],"diet":[105,142,218],"taking":[107,220],"empagliflozin.":[108],"A":[109],"51-year-old":[110],"man":[111],"was":[112,124],"hospitalized":[113],"nausea":[115],"vomiting,":[117],"investigations":[119],"revealed":[120],"metabolic":[121],"acidosis.":[122],"diagnosed":[125],"from":[126],"information":[128],"medications":[130],"his":[132],"drug":[133],"notebook":[134],"history":[137],"eating":[139],"(1900":[143],"kcal,":[144],"consisting":[145],"5.7%":[147],"carbohydrate,":[148],"21.1%":[149],"protein,":[150],"47.3%":[151],"fat":[152],"25.9%":[154],"alcohol)":[155],"for":[156,179],"4":[157],"d.":[158],"The":[159],"improved":[161],"infusion":[163],"acetated":[165],"Ringer's":[166],"solution":[167],"5%":[169],"administration":[172],"regular":[174],"insulin.":[175],"It":[176],"is":[177],"necessary":[178],"physicians":[180],"pharmacists":[182],"thoroughly":[184],"inform":[185],"effects":[190],"Patients":[203],"should":[204],"also":[205],"be":[206],"advised":[207],"higher":[210],"risk":[211],"associated":[214],"inhibitors.":[222]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2986313496","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-11-22T00:00:00"}
